Novel genetic associations with anxiety unveiled in comprehensive study of over 1.2 million people

Sidu­ma Ther­a­peu­tics, a Yale spin­out from Arv­inas sci­en­tif­ic founder Craig Crews, has closed, a spokesper­son for the com­pa­ny con­firmed to End­points News via email Thurs­day.

Chro­ma Med­i­cine laid off an undis­closed num­ber of em­ploy­ees ear­li­er this week, as the pri­vate­ly held start­up fo­cus­es its re­sources on mov­ing its first epi­ge­net­ic